Beneficial effects of soy protein consumption on bone quality have been reported. The effects of other dietary protein sources such as whey protein hydrolysate (WPH) and rice protein isolate (RPI) on bone growth have been less well examined. The current study compared effects of feeding soy protein isolate (SPI), WPH and RPI for 14 d on tibial bone mineral density (BMD) and bone mineral content (BMC) in intact and ovariectomized (OVX) rapidly growing female rats relative to animals fed casein (CAS). The effects of estrogenic status on responses to SPI were also explored. Tibial peripheral quantitative computerized tomography (pQCT) showed all three protein sources had positive effects on either BMD or BMC relative to CAS (P < 0.05), but SPI had greater effects in both intact and OVX female rats. SPI and E2 had positive effects on BMD and BMC in OVX rats (P < 0.05). However, trabecular BMD was lower in a SPI + E2 group compared to a CAS + E2 group. In OVX rats, SPI increased serum bone formation markers, and serum from SPI-fed rats stimulated osteoblastogenesis in ex vivo. SPI also suppressed the bone resorption marker RatLaps (P < 0.05). Both SPI and E2 increased alkaline phosphatase gene expression in bone, but only SPI decreased receptor activator of nuclear factor-κB ligand (RANKL) and estrogen receptor gene expression (P < 0.05). These data suggest beneficial bone effects of a soy diet in rapidly growing animals and the potential for early soy consumption to increase peak bone mass.
Get full access to this article
View all access options for this article.
References
1.
National Osteoporosis Foundation. http://www.nof.org (accessed July 6, 2003).
2.
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc288:321–333, 2002.
3.
Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet5:71–118, 2004.
4.
Sacks FM. Dietary phytoestrogens to prevent cardiovascular disease: early promise unfulfilled. Circulation111(4):385–387, 2005.
5.
Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr68: 1333S–1346S, 1998.
6.
Massey LK. Dietary animal and plant protein and human bone health: a whole foods approach. J Nutr133(3):862S–865S, 2003.
7.
Yan L, Zhou B, Prentice A, Wang X, Golden MH. Epidemiological study of hip fracture in Shenyang, People’s Republic of China. Bone24(2):151–155, 1999.
8.
Lacey JM, Anderson JJ, Fujita T, Yoshimoto Y, Fukase M, Tsuchie S, Koch GG. Correlates of cortical bone mass among premenopausal and postmenopausal Japanese women. J Bone Miner Res6(7):651–659, 1991.
9.
Ginty F, Prentice A. Can osteoporosis be prevented with dietary strategies during adolescence? Br J Nutr92(1):5–6, 2004.
10.
Anderson JJ, Garner SC. Phytoestrogens and bone. Baillieres Clin Endocrinol Metab12(4):543–557, 1998.
11.
Gao YH, Yamaguchi M. Anabolic effect of daidzein on cortical bone in tissue culture: comparison with genistein effect. Mol Cell Biochem194(1–2):93–97, 1999.
12.
Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr130(7):1675–1681, 2000.
13.
Setchell KD. Soy isoflavones—benefits and risks from nature’s selective estrogen receptor modulators (SERMs). J Am Coll Nutr20(5 Suppl):354S–362S, 2001.
14.
Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med137(10):805–813, 2002.
15.
Barnes S. Soy isoflavones—phytoestrogens and what else? J Nutr134(5):1225S–1228S, 2004.
16.
Weaver CM, Cheong JM. Soy isoflavones and bone health: the relationship is still unclear. J Nutr135(5):1243–1247, 2005.
17.
Kennedy AR. The evidence for soybean products as cancer preventive agents. J Nutr125(3 Suppl):733S–743S, 1995.
18.
Toba Y, Takada Y, Yamamura J, Tanaka M, Matsuoka Y, Kawakami H, Itabashi A, Aoe S, Kumegawa M. Milk basic protein: a novel protective function of milk against osteoporosis. Bone27(3):403–408, 2000.
19.
Uenishi K, Ishida H, Toba Y, Aoe S, Itabashi A, Takada Y. Milk basic protein increases bone mineral density and improves bone metabolism in healthy young women. Osteoporos Int18(3):385–390, 2007.
20.
Spence LA, Lipscomb ER, Cadogan J, Martin B, Wastney ME, Peacock M, Weaver CM. The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study. Am J Clin Nutr81(4):916–922, 2005.
21.
Zhao Y, Martin BR, Wastney ME, Schollum L, Weaver CM. Acute versus chronic effects of whey proteins on calcium absorption in growing rats. Exp Biol Med (Maywood)230(8):536–542, 2005.
22.
Black RE, Williams SM, Jones IE, Goulding A. Children who avoid drinking cow milk have low dietary calcium intakes and poor bone health. Am J Clin Nutr76(3):675–680, 2002.
23.
Gao X, Wilde PE, Lichtenstein AH, Tucker KL. Meeting adequate intake for dietary calcium without dairy foods in adolescents aged 9 to 18 years (National Health and Nutrition Examination Survey 2001–2002). J Am Diet Assoc106(11):1759–1765, 2006.
24.
Yu S, Fang N, Li Q, Zhang J, Luo H, Ronis M, Badger TM. In vitro actions on human cancer cells and the liquid chromatography-mass spectrometry/mass spectrometry fingerprint of phytochemicals in rice protein isolate. J Agric Food Chem54(12):4482–4492, 2006.
25.
Akihisa T, Yasukawa K, Yamaura M, Ukiya M, Kimura Y, Shimizu N, Arai K. Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects. J Agric Food Chem48(6):2313–2319, 2000.
26.
Sugano M, Tsuji E. Rice bran oil and cholesterol metabolism. J Nutr127(3):521S–524S, 1997.
27.
Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr123(11):1939–1951, 1993.
28.
Badger TM, Ronis MJ, Hakkak R. Developmental effects and health aspects of soy protein isolate, casein, and whey in male and female rats. Int J Toxicol20(3):165–174, 2001.
29.
Fang N, Yu S, Badger TM. Comprehensive phytochemical profile of soy protein isolate. J Agric Food Chem52(12):4012–4020, 2004.
30.
Morta T, Kiriyama S. Mass production method for rice protein isolate and nutritional evaluation. J Food Sci58:1393–1397, 1993.
31.
Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology143(6):2376–2384, 2002.
32.
Chen JR, Haley RL, Hidestrand M, Shankar K, Liu X, Lumpkin CK, Simpson PM, Badger TM, Ronis MJ. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther319(3):1182–1190, 2006.
33.
Reinwald S, Weaver CM. Soy isoflavones and bone health: a double-edged sword? J Nat Prod69(3):450–459, 2006.
34.
Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr81(5):1072–1079, 2005.
35.
Gu L, House SE, Prior RL, Fang N, Ronis MJ, Clarkson TB, Wilson ME, Badger TM. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr136(5):1215–1221, 2006.
36.
Kuipers BJ, Bakx EJ, Gruppen H. Functional region identification in proteins by accumulative-quantitative peptide mapping using RP-HPLC-MS. J Agric Food Chem55(23):9337–9344, 2007.
37.
Takada Y, Aoe S, Kumegawa M. Whey protein stimulated the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun223(2):445–449, 1996.
38.
Matsuoka Y, Serizawa A, Yoshioka T, Yamamura J, Morita Y, Kawakami H, Toba Y, Takada Y, Kumegawa M. Cystatin C in milk basic protein (MBP) and its inhibitory effect on bone resorption in vitro. Biosci Biotechnol Biochem66(12):2531–2536, 2002.
39.
Balasch J. Sex steroids and bone: current perspectives. Hum Reprod Update9(3):207–222, 2003.
40.
Marcus R. Post-menopausal osteoporosis. Best Pract Res Clin Obstet Gynaecol6(3):309–327, 2002.
41.
Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol87(5 Pt 2):897–904, 1996.
42.
Mäkelä SI, Pylkkänen LH, Santti RS, Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nutr125(3):437–445, 1995.
43.
Tivesten A, Movérare-Skrtic S, Chagin A, Venken K, Salmon P, Vanderschueren D, Sävendahl L, Holmäng A, Ohlsson C. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats. J Bone Miner Res19(11):1833–1839, 2004.
44.
Plant A, Tobias JH. Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice. J Cell Biochem82(4):683–691, 2001.
45.
Cai DJ, Zhao Y, Glasier J, Cullen D, Barnes S, Turner CH, Wastney M, Weaver CM. Comparative effect of soy protein, soy isoflavones, and 17 beta-estradiol on bone metabolism in adult ovariectomized rats. J Bone Miner Res20(5):828–839, 2005.
46.
Chow JW, Lean JM, Abe T, Chambers TJ. The anabolic effect of 17 beta-oestradiol on the trabecular bone of adult rats is suppressed by indomethacin. J Endocrinol133(2):189–195, 1992.
47.
Diel P, Hertrampf T, Seibel J, Laudenbach-Leschowsky U, Kolba S, Vollmer G. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats. J Steroid Biochem Mol Biol102(1–5):60–70, 2006.
48.
Gallo D, Zannoni GF, Martinelli E, Ferlini C, Fabrizi M, Riva A, Morazzoni P, Bombardelli E, Scambia G. Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland. Menopause13(1):72–79, 2006.
